Sublingual immunotherapy: Allergen specific or placebo effect?

Journal of Allergy and Clinical Immunology

Volumn 128, Issue 2, 2011, Pages 430-

  Kette, Frank ^a   Smith, William ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GRASS POLLEN VACCINE;

CLINICAL FEATURE; GRASS POLLEN; HEALTH SURVEY; HUMAN; LETTER; PLACEBO EFFECT; POLLEN ALLERGY; PRIORITY JOURNAL; PRURITUS; SUBLINGUAL IMMUNOTHERAPY; THROAT IRRITATION; TREATMENT OUTCOME;

ALLERGENS; ANTIGENS, PLANT; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; PHLEUM; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL;

EID: 79960999096     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.04.048     Document Type: Letter

References (6)

1. Blaiss M, Maloney J, Nolte H, Gawchik S, Yao R, Skoner D. Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents. J Allergy Clin Immunol 2011;127:64-71, e4.
2. Nelson HS, Nolte H, Creticos P, Maloney J, Wu J, Bernstein DI. Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults. J Allergy Clin Immunol 2011;127:72-80, e2.
3. Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;118:434-40. (Pubitemid 44160721)
4. Didier A, Malling HJ, Worm M, Horak F, Jager S, Montagut A, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007;120:1338-45. (Pubitemid 350225683)
5. Wahn U, Tabar A, Kuna P, Halken S, Montagut A, de Beaumont O, et al. Efficacy and safety of five grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009;123:160-6.
6. Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L, et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009;123:167-73, e7.